Treatment with 5-azacytidin upregulates the expression of CD20 in CD20-negative B cell acute lymphoblastic leukemia: a case report

MeSH terms

• Adult
• Antibodies, Monoclonal, Murine-Derived / therapeutic use
• Antigens, CD20 / biosynthesis*
• Antigens, CD20 / genetics
• Antimetabolites, Antineoplastic / administration & dosage
• Antimetabolites, Antineoplastic / pharmacology*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Azacitidine / administration & dosage
• Azacitidine / pharmacology*
• Combined Modality Therapy
• DNA (Cytosine-5-)-Methyltransferase 1
• DNA (Cytosine-5-)-Methyltransferases / antagonists & inhibitors
• Enzyme Inhibitors / pharmacology
• Fatal Outcome
• Female
• Gene Expression Regulation, Leukemic / drug effects*
• Hematopoietic Stem Cell Transplantation
• Histone Deacetylase Inhibitors / administration & dosage
• Humans
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
• Recurrence
• Rituximab
• Salvage Therapy
• Transplantation, Homologous
• Up-Regulation / drug effects
• Valproic Acid / administration & dosage